Evidence map›Paper›PMID 27231001›Full record

ArticleBMJ open2016

Retrospective hepatitis C seroprevalence screening in the antenatal setting-should we be screening antenatal women?

Chloe Orkin, Anna Jeffery-Smith, Graham R Foster, C Y William Tong

Abstract read
In one paragraph

Article in BMJ open, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Feasibility and Acceptability of Antenatal Hepatitis C Screening: A Pilot Study.Canadian journal of gastroenterology & hepatology · 2024
    Article
  3. Review
  4. Article
  5. Article
  6. Prospective cohort study of children exposed to hepatitis C virus through a pregnancy screening program.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021
    Article
  7. Article
  8. Hepatitis C in Pregnancy.Diseases (Basel, Switzerland) · 2018
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chloe OrkinDepartment of Infection and Immunology, Barts Health NHS Trust, London, UK.
Anna Jeffery-SmithDepartment of Infection, Barts Health NHS Trust, London, UK.
Graham R FosterQueen Mary University London, Blizard Institute of Cell and Molecular Science, London, UK.
C Y William TongDepartment of Infection, Barts Health NHS Trust, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesAn unlinked anonymous seroprevalence study was conducted to estimate the prevalence of hepatitis C virus (HCV) infection in samples derived from antenatal clinic attendees at 2 East London Hospitals. An unexpectedly high HCV seroprevalence of 2.6% (1.2% viraemic) had been revealed during an unlinked study of the emergency department at 1 of these hospitals.

design1000 stored residual samples were tested for HCV antibody (anti-HCV) and reactive samples were further tested for HCV RNA. The study was reviewed by the East Midland NRES ethics committee project ID 181154, approval number 15/WS/0125.

resultsThe anti-HCV reactivity rate was 0.5% (5/1000) with 0.1% (1/1000) confirmed viraemic. Prevalence for the other blood-borne viruses was higher: 1% (10/1000) were hepatitis B surface antigen positive and 0.3% were HIV antigen/antibody positive (3/1000). There were no co-infections.

conclusionsMore data to establish the prevalence of HCV in the antenatal population is needed. The addition of anti-HCV testing to the well-established antenatal screening programme provides a unique opportunity to impact on the health of pregnant women, their children, partners and future pregnancies in this new era of treatment for hepatitis C.

Indexed as

AdolescentAdultFemaleHepacivirusHepatitis B Surface AntigensHepatitis CHepatitis C AntibodiesHIV SeropositivityHumansLondonMass ScreeningMiddle AgedPregnancyPregnancy Complications, InfectiousPrenatal CarePrevalenceHepatitis B Surface AntigensHepatitis C AntibodiesRNA, ViralVIROLOGY

Identifiers

PMID27231001
PMCPMC4885317

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.